The global vitamin B12 market is witnessing steady growth, driven by increasing awareness of nutritional deficiencies, rising demand for dietary supplements, and growing adoption of fortified foods. Vitamin B12 plays a crucial role in red blood cell formation, neurological function, and DNA synthesis, making it essential for overall health.

The vitamin B12 market reached US$ 373.93 million in 2025 and is expected to reach US$ 632.93 million by 2033, growing at a CAGR of 6.80% during the forecast period (2026–2033). Growth is supported by the rising prevalence of vitamin deficiencies, particularly among vegetarian and vegan populations, and increasing healthcare awareness globally.

Download Sample : https://www.datamintelligence.com/download-sample/vitamin-b12-market 

Market Segmentation

By Product: Cyanocobalamin; Methylcobalamin; Hydroxocobalamin; Others.

By Source: Synthetic; Natural.

By Composition: Tablets; Capsules; Liquid; Injectable; Others.

By Application: Pharmaceuticals; Food & Beverages; Animal Feed; Dietary Supplements; Others.

By Region: North America; Latin America; Europe; Asia-Pacific; Middle East & Africa.

Regional Insights

North America: A leading region driven by high consumer awareness, strong demand for dietary supplements, and presence of major pharmaceutical companies.

Europe: Significant market share supported by increasing health consciousness and widespread use of fortified foods.

Asia-Pacific: Expected to witness robust growth due to rising population, increasing disposable income, and growing awareness of nutritional health.

Latin America & Middle East & Africa: Emerging regions with growing demand for supplements and improving healthcare access.

Key Market Drivers

Rising prevalence of vitamin deficiencies: Increasing cases of B12 deficiency, especially among aging populations and plant-based diet consumers.

Growing demand for dietary supplements: Consumers are increasingly adopting preventive healthcare practices.

Expansion of fortified food products: Food manufacturers are incorporating vitamin B12 into various products.

Increasing awareness of health and wellness: Rising focus on nutrition and preventive healthcare is driving demand.

Market Challenges

Side effects and dosage concerns: Improper intake may lead to health complications.

Regulatory compliance: Stringent regulations regarding supplement quality and labeling.

Limited natural sources: Vitamin B12 is primarily found in animal-based products, limiting availability for certain populations.

Price fluctuations in raw materials: Can impact production costs and pricing.

Leading Market Players

Key players in the vitamin B12 market include Hoffmann-La Roche Ltd., Bayer AG, Merck Group, Johnlee Pharmaceuticals Pvt. Ltd., American Regent Inc., Koninklijke DSM N.V., EUROAPI, Pharmavit, Supreem Pharmaceuticals Mysore Pvt. Ltd., and Arshine Feed Additives Co., Ltd. These companies focus on product innovation, expanding production capacity, and strengthening distribution networks.

Recent Industry Developments

Introduction of advanced formulations such as sublingual tablets and sprays for better absorption.

Expansion of fortified food and beverage product lines.

Strategic partnerships between pharmaceutical and nutraceutical companies.

Increasing investments in research and development for improved bioavailability.

Conclusion

The vitamin B12 market is poised for steady growth, driven by rising health awareness, increasing demand for supplements, and expansion of fortified food products. While challenges such as regulatory compliance and limited natural sources persist, the overall outlook remains positive with continued innovation and growing global demand.